Developing new methods for targeted chemical modifications of proteins and drugs
Official title: Peptide-Conjugated Palladium Oxidative Addition Complexes for Site-Selective Arylation Chemistry
Funded at Massachusetts Institute of Technology · NIH-10912476 · Data updated 2026-11-12
This study is exploring new ways to change proteins in a targeted way using special chemicals, which could help make medicines work better and lead to new treatments for various health conditions.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $74,284 |
| NIH project number | 5F32GM150211-02 |
| Project ID | NIH-10912476 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research would include individuals with conditions that could benefit from advanced drug therapies or biomaterials.
✕Less likely to help
Patients who are not seeking new treatment options or those with conditions that do not involve protein modifications may not benefit from this research.
What this research studies
This research focuses on creating innovative chemical methods to modify biomolecules, particularly proteins, in a precise manner. By using palladium complexes, the team aims to achieve site-selective modifications that can enhance the effectiveness of drugs and biomaterials. The approach involves attaching peptide sequences to these complexes, allowing for targeted interactions with specific proteins. This could lead to advancements in drug development and the creation of new therapeutic agents.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted therapies for various diseases.
How similar studies have gone: Previous research has shown promise in similar chemical modification techniques, indicating potential for success in this novel approach.
Where this research is happening
-
Massachusetts Institute of Technology
Cambridge, United States Active
Researchers
- Principal investigator: Kutateladze, Dennis a. — Massachusetts Institute of Technology
- Study coordinator: Kutateladze, Dennis a.
Related research
Other NIH-funded projects on the same topics.
-
PhysioNet: A trusted, open data repository for clinical and physiological data
A publicly accessible platform provides curated clinical and physiological data and tools to help researchers develop and test AI models for better healthcare.
-
Dormancy in Triple-Negative Breast Cancer: How Liver and Skin Metastases Go Quiet or Reactivate
Researchers will study how dormant cancer cells in liver and skin metastases of triple-negative breast cancer become quiescent or wake up, using organ-on-chip models and single-cell analysis to map chromatin states.
-
Single-cell, label-free mapping of senescence in tissues with Raman imaging and spatial genomics
A project to map how senescent cells differ across tissues using a noninvasive Raman imaging method combined with spatial genomics.
-
Structures and dynamics of virus ion channels
This project studies the tiny channels in certain influenza and coronavirus viruses to understand how they let ions pass through and contribute to disease.
-
Prospect: Stem Cell Models for Early-Onset Colorectal Cancer Prevention
Researchers at MIT are using stem cell models to understand why colorectal cancer is rising in people under 50 and how to prevent it.
-
MATCHMAKERS: AI tools to predict TCR binding and design
Researchers are building AI tools to predict how T cell receptors recognize tumor antigens, with aims to help improve targeted immunotherapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.